Preclinical studies demonstrate potent NF-kB inhibition and IL-10 elevation at microgram-level doses
Commercial GLP-1 patches dont contain actual GLP-1 medications and cant deliver the same effects
It's crucial to discuss medical history and potential risks with a health care provider before using these medications, as these drugs are not suitable for people with certain medical conditions, including those with a history of medullary thyroid cancer, type 1 diabetes, pancreatitis, or severe gastrointestinal disease
Tirzepatide (Zepbound): Showed up to 20.9% average weight reduction at the highest dose in the SURMOUNT-1 trial
Medical weight management works best when combined with nutrition support, physical activity, hydration, sleep management, and regular follow-up
Disclaimer : The information provided is for general informational purposes only and is not intended as medical advice